Antifibrotic Effects of Smad4 Small Interfering RNAs in Injured Skeletal Muscle After Acute Contusion

Abstract

Muscle injuries are common musculoskeletal problems encountered in sports medicine clinics. In this study, we examined the effect of lentivirus-mediated small interfering RNA (siRNA) targeting Smad4 on the suppression of the fibrosis in injured skeletal muscles. We found that Smad4-siRNA could efficiently knock down the expression of Smad4 in the C2C12 myoblast cells and in the contunded mice gastrocnemius muscle. The expression of mRNA level of Smad4 decreased to 11% and 49% compared to the control group, respectively, and the expression of protein level decreased to 13% and 57% respectively. Moreover, the lentivirus-mediated siRNA was stably transfected only into the skeletal muscle and not into the liver of the animals. In contunded mice gastrocnemius, the collagenous and vimentin-positive area in the Smad4 siRNA group reduced to 36% and 37% compared to the control group, respectively. Furthermore, compared to the scrambled Smad4 siRNA-injected mice and PBS control-injected mice, the muscle function of the mice injected with lentivirus-mediated Smad4 siRNA improved in terms of both fast-twitch and tetanic strength (P<0.05). The results suggest that the gene therapy of inhibiting Smad4 by lentivirus-mediated siRNA could be a useful approach to prevent scar tissue formation and improve the function of injured skeletal muscle.

siRNA - fibrosis - lentivirus - Smad4 - muscle injuries

References

• 1 Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily.  Science. 2002;  296 1646-1647
• 2 Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis.  N Engl J Med. 1994;  331 1286-1292
• 3 Chan YS, Li Y, Foster W, Fu FH, Huard J. The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury.  Am J Sports Med. 2005;  33 43-51
• 4 Depeyre C, Chen-Kuo-Chang M, Payet O, Cornille K, Muller A, Lenaers G, Hamel C, Arné JL, Arndt C. A murine model of transitory optic neuropathy based on small interference RNA-induced OPA1 silencing in vivo (gene mutation associated with Kjerâs disease).  J Fr Opthalmol. 2006;  29 875-880
• 5 Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.  Nature. 2001;  411 494-498
• 6 Foster W, Li Y, Usas A, Somogyi G, Huard J. Gamma interferon as an antifibrosis agent in skeletal muscle.  J Orthop Res. 2003;  21 798-804
• 7 Garrett Jr WE. Muscle strain injuries.  Am J Sports Med. 1996;  24 S2-S8
• 8 Goto Y, Manabe N, Uchio-Yamada K, Yamaguchi-Yamada M, Inoue N, Yamamoto Y, Ogura A, Nagano N, Miyamoto H. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation.  Cell Tissue Res. 2004;  315 209-221
• 9 Hannon GJ. RNA interference.  Nature. 2002;  418 244-251
• 10 Harriss DJ, Atkinson G. International Journal of Sports Medicine – Ethical Standards in Sport and Exercise Science Research.  Int J Sports Med. 2009;  30 701-702
• 11 Huard J, Li Y, Fu FH. Muscle injuries and repair: current trends in research.  J Bone Joint Surg Am. 2002;  84-A 822-832
• 12 Hurme T, Kalimo H, Sandberg M, Lehto M, Vuorio E. Localization of type I and III collagen and fibronectin production in injured gastrocnemius muscle.  Lab Invest. 1991;  64 76-84
• 13 Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derived from epithelium during tissue fibrosis.  J Clin Invest. 2002;  110 341-350
• 14 Kasemkijwattana C, Menetrey J, Somogyl G, Moreland MS, Fu FH, Buranapanitkit B, Watkins SC, Huard J. Development of approaches to improve the healing following muscle contusion.  Cell Transplant. 1998;  7 585-598
• 15 Kopp J, Preis E, Said H, Hafemann B, Wickert L, Gressner AM, Pallua N, Dooley S. Abrogation of transforming growth factor-beta signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts.  J Biol Chem. 2005;  280 21570-21576
• 16 Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response.  FASEB J. 2004;  18 816-827
• 17 Li F, Ruan H, Fan C, Zeng B, Zeng B, Wang C, Wang X. Efficient inhibition of the formation of joint adhesions by ERK2 small interfering RNAs.  Biochem Biophys Res Commun. 2010;  391 795-799
• 18 Li Y, Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle.  Am J Pathol. 2002;  161 895-907
• 19 Lois C, Hong EJ, Pease S, Brown EJ, Brown EJ, Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors.  Science. 2002;  295 868-872
• 20 Massagué J. TGF-beta signal transduction.  Annu Rev Biochem. 1998;  67 753-791
• 21 McCartney-Francis NL, Frazier-Jessen M, Wahl SM. TGF-beta: a balancing act.  Int Rev Immunol. 1998;  16 553-580
• 22 Menetrey J, Kasemkijwattana C, Day CS, Bosch P, Vogt M, Fu FH, Moreland MS, Huard J. Growth factors improve muscle healing in vivo.  J Bone Joint Surg Br. 2000;  82 131-137
• 23 Nozaki M, Li Y, Zhu J, Ambrosio F, Uehara K, Fu FH, Huard J. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth.  Am J Sports Med. 2008;  36 2354-2362
• 24 Philippe S, Sarkis C, Barkats M, Mammeri H, Ladroue C, Petit C, Mallet J, Serguera C. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.  Proc Natl Acad Sci USA. 2006;  103 17684-17689
• 25 Sato K, Li Y, Foster W, Fukushima K, Badlani N, Adachi N, Usas A, Fu FH, Huard J. Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis.  Muscle Nerve. 2003;  28 365-372
• 26 Schnaper HW, Hayashida T, Hubchak SC, Poncelet AC. TGF-beta signal transduction and mesangial cell fibrogenesis.  Am J Physiol. 2003;  284 F243-F252
• 27 Ulloa L, Doody J, Massagué J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.  Nature. 1999;  397 710-713
• 28 Verrecchia F, Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation.  J Invest Dermatol. 2002;  118 211-215

Correspondence